Who is sponsoring NCT03666065?

NCT03666065 is sponsored by Yale University.

What condition does NCT03666065 study?

NCT03666065 studies Type1diabetes.

What is the status of NCT03666065?

NCT03666065 is currently COMPLETED.

Last reviewed 2023-08-14 · How we verify

Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients

NCT03666065 EARLY_PHASE1 COMPLETED

The aim of this study is to compare the pharmacokinetic (PK) profile of diluted insulin aspart (U25) with undiluted insulin aspart (U100) in school-aged children and adolescents with type 1 diabetes (T1D) utilizing the euglycemic clamp technique and a standardized meal in a controlled research environment. The investigators hypothesize that dilution of insulin aspart (U25) will alter the PK properties as compared to undiluted aspart.

Details

Lead sponsor	Yale University
Phase	EARLY_PHASE1
Status	COMPLETED
Enrolment	3
Start date	Wed Jan 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jun 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Type1diabetes

Interventions

Aspart insulin

Countries

United States